SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19285621
Source:
http://linkedlifedata.com/resource/pubmed/id/19285621
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0020542
,
umls-concept:C0033554
,
umls-concept:C0087111
,
umls-concept:C0442027
,
umls-concept:C1883712
pubmed:issue
3
pubmed:dateCreated
2009-3-16
pubmed:abstractText
The aim of our study was to describe the efficacy of addition of intravenous or subscutaneous prostanoids in idiopathic pulmonary arterial hypertension (PAH) patients deteriorating on bosentan or on bosentan-sildenafil.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9102703
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Epoprostenol
,
http://linkedlifedata.com/resource/pubmed/chemical/Piperazines
,
http://linkedlifedata.com/resource/pubmed/chemical/Purines
,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides
,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfones
,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/bosentan
,
http://linkedlifedata.com/resource/pubmed/chemical/sildenafil
,
http://linkedlifedata.com/resource/pubmed/chemical/treprostinil
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1557-3117
pubmed:author
pubmed-author:BoonstraAncoA
,
pubmed-author:JacobsWouterW
,
pubmed-author:MarcusJ TimJT
,
pubmed-author:PostmusPieter EPE
,
pubmed-author:TurekM AMA
pubmed:issnType
Electronic
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
280-4
pubmed:meshHeading
pubmed-meshheading:19285621-Administration, Oral
,
pubmed-meshheading:19285621-Adult
,
pubmed-meshheading:19285621-Antihypertensive Agents
,
pubmed-meshheading:19285621-Drug Therapy, Combination
,
pubmed-meshheading:19285621-Epoprostenol
,
pubmed-meshheading:19285621-Female
,
pubmed-meshheading:19285621-Humans
,
pubmed-meshheading:19285621-Hypertension, Pulmonary
,
pubmed-meshheading:19285621-Male
,
pubmed-meshheading:19285621-Piperazines
,
pubmed-meshheading:19285621-Purines
,
pubmed-meshheading:19285621-Sulfonamides
,
pubmed-meshheading:19285621-Sulfones
,
pubmed-meshheading:19285621-Vasodilator Agents
pubmed:year
2009
pubmed:articleTitle
Addition of prostanoids in pulmonary hypertension deteriorating on oral therapy.
pubmed:affiliation
Department of Pulmonology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't